These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 21537038

  • 21. Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarket evaluation reports--FDA. Proposed rule.
    Fed Regist; 1998 Apr 10; 63(69):17744-71. PubMed ID: 10177764
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The approval process for hyperthermic intraoperative intraperitoneal chemotherapy.
    Sugarbaker PH, Clarke L.
    Eur J Surg Oncol; 2006 Aug 10; 32(6):637-43. PubMed ID: 16630703
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR.
    Food Drug Law J; 2009 Aug 10; 64(1):183-223. PubMed ID: 19998746
    [Abstract] [Full Text] [Related]

  • 26. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R.
    J Natl Cancer Inst; 2005 May 18; 97(10):708-9. PubMed ID: 15900036
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept.
    Mogielnicki M, Swieczkowski D, Bachorski W, Zuk G, Gilis-Malinowska N, Zarzeka A, Merks P, Gruchala M, Jaguszewski M.
    Cardiol J; 2016 May 18; 23(5):515-517. PubMed ID: 27723064
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA.
    Ugeskr Laeger; 2003 Apr 14; 165(16):1648-9. PubMed ID: 12756819
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology.
    McKee AE, Farrell AT, Pazdur R, Woodcock J.
    Oncologist; 2010 Apr 14; 15 Suppl 1():13-8. PubMed ID: 20237212
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. When EMA and FDA decisions conflict: differences in patients or in regulation?
    Wolfe SM.
    BMJ; 2013 Aug 21; 347():f5140. PubMed ID: 23970394
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Off-label use in oncology. The Italian choice].
    Felicetti V, Gremigni U, Cifaldi L.
    Recenti Prog Med; 2008 Dec 21; 99(12):612-5. PubMed ID: 19388222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.